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2Abstract: Currently HPLC/MS is the state of the art tool for
environmental/drinking water perfluorooctane sulfonate(PFOS) monitoring. PFOS
can bind to peroxisomal proliferator-activated receptor-alpha (PPARα), which forms
heterodimers with retinoid X receptors (RXRs) and binds to PPAR response elements.
In this bioassay free PFOS in water samples competes with immobilized PFOS in
ELISA plates for a given amount of PPARα-RXRα. It can be determined indirectly by
immobilizing PPARα-RXRα-PFOS complex to another plate coated with PPARα
antibody and subsequent measuring level of PPARα-RXRα by using biotin-modified
PPARα-RXRα probes-quantum dots- streptavidin detection system. The rapid and
high-throughput bioassay demonstrated a detection limit of 2.5 ng/l with linear range
between 2.5 ng/l – 75 ng/l. Detection results of environmental water samples were
highly consistent between the bioassay and HPLC/MS.
Capsule: We developed a rapid and high-throughput bioassay for monitoring of PFOS
in environmental water samples.
Key words: High-throughput; Monitoring; Quantum dots Bioassay; Perfluorooctane
sulfonate.
31. Introduction
Perfluorooctane sulfonate (PFOS) is a well known member of the large family of
perfluorinated chemicals (PFCs), which are characterized by a fully fluorinated
hydrophobic linear carbon chain attached to various hydrophilic heads. PFOS is also a
final degradation product of a group of precursor PFCs (Lau et al., 2007). PFCs have
been manufactured for over 50 years. As surfactants and surface protectors, these
chemicals have been used as coatings in a wide range of industry and consumer
products, including paper, carpets, leather, food containers and fabric. PFCs also act
as performance chemicals in products such as fire-fighting foams, floor polishes, and
shampoos(Renner, 2001; Olsen et al., 2005).
Owing to the presence of the strong C-F bonds in their chemical structures, PFCs
are stable against many chemical reactions and non-biodegradable in the environment
and in activated sewage sludge(Brooke, 2004). The total global emission of PFOS is
estimated to be 6.5-130 tones with 98% being in water and 2% in air(Rumsby et al.,
2009). It has been reported that the level of PFOS in the rivers in China ranged from
less than 1 ng/l to greater than 20 ng/l, reflecting the difference in environmental
release from different regions (So et al., 2007; Chen, 2009). The samples from the
river near Shanghai have the highest PFOS level, which is in concordance with the
fact that there are many PFC manufacturers/users in and around Shanghai(Chen,
2009). The levels of PFCs in the lakes/rivers and drink waters are very similar,
indicating the ineffectiveness of current water treatment in removing these
4chemicals(Rumsby et al., 2009).
PFCs have been shown to accumulate in animals including humans. A mean
elimination half-life of 5.4 years has been reported(Olsen et al., 2007). The blood
concentration of PFOS varies greatly between different regions and countries. It
appeared that among the several countries, China has the highest blood concentration
of PFOS(Chen, 2009). Several PFCs including PFOS can bind to and therefore
activate the peroxisomal proliferator-activated receptor-alpha (PPARα) (of human, rat
and mouse), which forms heterodimers with retinoid X receptors (RXRs) and binds to
PPAR response elements (PPREs) within the promoter regions of many genes. These
genes are involved in a number of biological processes including lipid metabolism
and utilization, inflammation, fetal growth, hormone and immune function(Rosen et
al., 2009). They may also play roles in cancer development(Lau et al., 2007).
Based on its environmental behavior and human health effect, PFOS has been
classified as very persistent, very bioaccumulative and toxic by the EU. Consequently,
the use of PFOS has been restricted and will eventually end in EU countries as early
as practical(2006a). Similar regulatory measures have also been taken in the United
States(2002; 2006b). Nevertheless, the wide and persistent presence of PFOS in the
environment presents a continuous threat to human health particularly in China, where
the activities in manufacturing and use of PFCs have increased during the last two
decade(Chen, 2009). Continues monitoring of PFOS in environmental waters is
necessary for evidence based policy making to protect environment and human health.
Most conducted PFC/PFOS monitoring programmes have mainly relied on the
5application of high performance liquid chromatography coupled with mass
spectrometry (HPLC/MS). Although current state of the art HPLC/MS has detection
limits well below 1 ng/l as summarized by(Zhang et al., 2010), the need for accessing
to the immobile and expensive equipments has hampered its use in a wide range of
conditions. More convenient, cost effective and high throughput alternatives are
desirable for large scale environmental water monitoring. The aim of the present study
was to develop a bioassay for detecting and monitoring the concentration of PFOS in
environmental water, based on the interaction of PFOS with PPARα-RXRα combined
with the use of quantum dots (QD) nanoparticles as a fluorescent marker. The QD
were conjugated with streptavidin (SA) that can bind to the PPARα-RXRα probes
labeled with biotin.
Although the sensitivity of the bioassay is lower compared with HPLC/MS, it is
convenient, low cost, and allows rapid and high throughput detection. Such detection
method is particularly useful for rapid screening for samples with concentration of
PFOS higher than 2.5 ng/l.
2. Materials and methods
2.1 Reagents and chemicals
All HPLC purified oligonucleotide probes labeled by biotins were synthesized by
Sangon Biotechnology Inc. (Shanghai, China). Quantum dots streptavidin conjugate
6(QD-SA) kit was purchased from JiaYuan Quantum Dots Co., Ltd (Wuhan, China).
QD-SA was diluted at 1:1000 in diluting buffer and stored at 4°C until use. PFOS was
purchased from Fluka (Buchs, Switzerland). Bovine serum albumin (BSA) and
dextran coated charcoal were purchased from Sigma-Aldrich Co. (St. Louis, MO,
USA). Rabbit polyclonal PPARα antibody (SC-9000) was purchased from Santa Cruz
Biotechnology (Santa Cruz, CA, USA). All reagents for nuclear extraction were
obtained from Roche Ltd. (Mannheim, Germany). Ultra-pure water (18 MΩ,
Barnstead International) was used to prepare all the solutions. Black 96-microwell
plates were purchased from Nunc Co., Ltd (Denmark).
2.2 Preparation of PPARα-RXRα
The PPARα-RXRα was extracted from the liver of male Sprague Dawley rat
according to the protocol described by Crinelli (Baptista et al., 2006). 20 µl aliquots
of nuclear extracts were stored at -80°C until use.
2.3 Preparation of biotin -modified probes for PPARα-RXRα binding
A pair of DNA probes tagged with biotin were designed and synthesized
according to the PPARα-RXRα heterodimer binding corequence (sense:
biotin-5’-AAAAACTGGGTCAAAGGTCT-3’, antisense:
biotin-5’-AGACCTTTGACCCAGTTTTT-3’')(Juge-Aubryet al., 1997). The
7synthetic single-stranded probes were dissolved in sterile TE buffer (10 mM Tris-HCL,
1 mM EDTA, pH=8.0) and melted in annealing buffer (10 mM Tris-HCL, 1 mM
EDTA, 50 mM NaCl, pH 8.0) at 72°C for 3 min, followed by cooling to 60°C for 1.5
min, further to 45°C for 1 min and 10°C for 3 min in a thermal cycler(Wang et al.,
2003; Li et al., 2006).
2.4 PFOS-BSA and PPARα antibody coating in 96 -microwell plates
PFOS-BSA was prepared according to the methods as described previously(Jones
et al., 2003). PFOS and BSA were first mixed at concentrations of 1 mM and 1.2 mM
respectively for 2 hr and then 0.025% of dextran coated charcoal was added in order
to absorb the free PFOS. After 30 min, the mixture was centrifuged at 10000 g for 10
min and the supernatant, which contained PFOS-BSA at concentration of 0.5 mM,
was collected. For coating with PFOS-BSA, 96-well black plates were filled with 200
µl/well PFOS-BSA diluted to 1 µM in coating buffer (NaHCO3/Na2CO3,50 mM,
pH=9.6). The plates were stored at 4°C for 12 hr before the supernatants were
removed and washed with PBS-Tween 20 (8 mM, pH=7.6, 0.05% Tween 20) for 3
times. The plates were also treated with blocking Buffer (1% BSA) for 2 hr.
For coating with PPARα antibody, the 96-well plates were filled with 200 µl/well
antibody at dilution of 1:400 in coating buffer (NaHCO3/Na2CO3, 50 mM, pH=9.6).
The rest of the coating procedure was the same as described above.
82.5 Quantum dots bioassay for PFOS detection
PFOS standards were made by dissolving PFOS in the pure water containing
0.05% DMSO at concentrations of 2.5 ng/l, 5 ng/l, 12.5 ng/l, 40 ng/l, 50 ng/l，and 75
ng/l. The solution without PFOS was used as control. 200 µl of each of the PFOS
standards and 2 µl of PPARα-RXRα extract were added to the 96-well plate coated
with PFOS-BSA. The plate was placed on a shaker for 1.5 hr at 37°C to allow full
combination of both free PFOS and PFOS-BSA with PPARα-RXRα. The supernatants
that containing the complex of PPARα-RXRα-PFOS were then transferred to another
plate coated with PPARα antibody. The plate was incubated for 1.5 hr at 37°C to
allow the reaction of PPARα-RXRα-PFOS with the antibody. After discarding the
supernatants and washing the plate with PBS-Tween 20 for 3 times, 100 µl /well
2×nucleoprotein binding buffer and 75 µl /well Ultra-pure water were added to the
plate. The plate was incubated for 30 min before 25 µl of biotin labeled DNA probe
(100 mM ) was added to each well. The plate was incubated for 1 hr at 37°C to allow
the probe to bind with PPARα-RXRα-PFOS. The QDs-SA was diluted at 1:1000 in
TBS and 200 µl/well added. After 2 hr incubation at 4°C, the result was processed by
an automatic fluorescence microplate reader at excitation and emission wavelengths
of 400 nm and 605 nm, respectively, according to the peak value of the QDs’
absorption and emission spectra (Fig.1).
2.6 PFOS detection by HPLC/MS
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HPLC/MSD system modified with low dead volume tubing. Separation of compounds
was performed using a 150× 2.1mm (5 μm) Zobax Extend C18 column (Aligent
Technologies, U.S.A). A 5 μl aliquot of the sample extract was injected into a guard
column (XDB-C8, 2.1mmi.d.×12.5mm, 5 μm; Agilent Technologies,U.S.A) that was
sequentially connected to Zorbax Extend C18 column with 1 mM ammonium acetate
solution (solvent A) and methanol (solvent B) as mobile phases, starting at 40% of
solvent B with flow rate of 0.2 ml/min . At 2 min the solvent B concentration was
increased to 60% and held till 5 min when its concentration was increased to 75%,
which was held until 11.5 min. The column temperature was kept constant at 40°C.
PFOS standards were identified and quantified using selective ion monitoring
(SIM) operating in negative electrospray ionization mode. The ion selected for
monitoring in this study was PFOS (m/z 499). Retention times for PFOS were
between 9.5 and 10.5 min. The desolvation gas temperature was 350°C at a flow rate
of 10 L/min. The collision cell was maintained at 30 psig. Capillary voltage was set at
1500 V with a fragmentor voltage of 70 V. A dwell time of 0.8 s was used to monitor
the ions. Correlation between peak areas and analyte concentrations (2.5-75 ng/l) was
determined by linear regression with a relative correlation coefficient of 0.9978 .
2.7 Recovery experiments
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The recovery experiments were conducted by spiking water samples with PFOS
standard. The water samples were then analyzed by Bioassay and by HPLC/MS using
the same detection parameters as used for analysis of standard samples. The
experiments were repeated for 8 times and the recovery rates were calculated by
comparing the concentrations derived from spiking samples and the standard
concentration.
2.8 Collection and pretreatment of environmental water samples
To minimize the adsorption of PFOS, plastic bottles made of polyethylene were
used for sampling. The containers for sample collection were washed with n-hexane,
petroleum ether and methanol before use according to GB/T5750.2-2006.
Environmental water samples were collected from the Yangtze River (Jiang’an
District Wuhan, China), Han River in Wuhan, waterworks in Wuhan and bottled
purified water in October 2009. The samples were taken at 20 cm below the water
surface in middle of Yangtze River and Han River. One little of water sample was
pretreated with filtration through 0.22 µm membrane to remove the solids in the water
at the speed of 1 drop per second, and then run through the C18 adsorption column
with the help of pump so that PFOS in water can be absorbed on the column. The
column was washed with 5 ml of methanol, dried by high-purity nitrogen and
dissolved in 1 ml of methanol. Due to its high sensitivity, the normal water samples
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for bioassay can be only pretreated with filtration through 0.22 µm membrane to
remove the solids without the enrichment by Solid-Phase Extraction.
2.9 Quantification of PFOS in environmental water samples with quantum dots
bioassay and HPLC/MS
To assess the reliability of the newly developed bioassay, the level of PFOS in
water samples was analyzed by the bioassay and compared with that derived with
HPLC/MS. Both assays were performed following the procedures as described
above.
3. Results
3.1 Scheme of the quantum dots bioassay
Basic principle of this bioassay is shown in Fig.2. In this system, the free PFOS in
water samples will compete with the immobilized PFOS in 96-well ELISA plate for a
given amount of PPARα-RXRα (Fig 2.1 and 2.2). The level of the free PFOS in the
samples can then be determined indirectly by immobilizing the PPARα-RXRα-PFOS
complex to another 96-well plate coated with PPARα antibody (Fig 2.3) and
subsequent measuring the level of PPARα-RXRα by using the biotin-modified
PPARα-RXRα probes-QD-SA detection system. The amount of PFOS is proportional
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to the fluorescence intensity of QDs, therefore PFOS detection can be quantitatively
achieved.
3.2 Validation of the bioassay for PFOS
To validate the bioassay system, PFOS standard solutions were measured using
both the bioassay and HPLC/MS. In the PFOS bioassay, the intensity of fluorescence
from each well was linearly related with the PFOS concentrations ranging from 2.5
ng/l to 75 ng/l (y = 19.112x-23.995, R2 = 0.9642) (Fig.3). The intensity of
fluorescence from blank control and standard concentration of 2.5ng/l was 0.35 and
1.31, respectively. The value of S/N was about 3, so the detection limit of this method
was 2.5 ng/l with the mean recovery being 107.8% (Fig.3).
In comparison, HPLC/MS demonstrated a limit of detection of 1ng/l and recovery
104.3%. The concentration range from 2.5 ng/l to 75ng/l was within its detection
linear range （y=2E-05x-26.479,R2 =0.9957）(Fig.4).
(Table. 1).
3.3 Quantification of PFOS in environmental water samples with the bioassay and
HPLC/MS.
To further assess the reliability of the bioassay, 3 water samples per place
collected were detected for PFOS concentration and the results were compared with
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that determined by HPLC/MS as shown in Table 1., suggesting that the novel bioassay
is reliable for PFOS quantification. HPLC/MS analysis also confirmed identity of the
analyst as PFOS (Fig.5).
(Table.2).
4. Discussion
In the present study, a novel bioassay has been successfully developed for
detection of PFOS in environmental water samples. In order to achieve reasonably
high sensitivity, QD nanoparticles were used to enhance the signals for detection in
the bioassay system. Over traditional fluorophores, QD nanoparticles have several
advantages that include a long fluorescent lifetime, high fluorescent
intensity(Ghasemi et al., 2009), broad excitation spectrum, narrow emission
spectrum, and large separation between the excitation and emission
wavelength(Baptista et al., 2006; Kjallman, 2008).
This study was initially designed for detection of PFOS, the method however can
also be applied for detection of several other PFCs that can bind to the PPARα.
Although the sensitivity of the bioassay is lower than HPLC/MS, the QDs bioassay is
rapid, convenient and high-throughput. It is particularly useful as a tool for rapid
screening for environmental water samples that contain high level concentration of
PFCs. The actual identities and concentration of the detected PFCs can be further
confirmed using HPLC/MS. The QDs bioassay can also be used to monitor large
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number of residential drinking water samples for PFOS content and evaluate the
effectiveness of PFOS-rich sewage treatment. If the concentration of PFOS in sewage
samples is higher than 75ng/L, we can dilute them to 1/10,1/100,1:1000 or more
before testing, and test them at one time for high-throughput of the bioassay. At last
one diluted sample must be in the detection range(2.5~75ng/L), then we can calculate
the concentration according to the sample’s dilution. Such detection method can
therefore serve as a complementary or an alternative tool to HPLC/MS for PFC
detection and monitoring in environmental waters.
The increase in manufacturing and application of PFOS and related chemicals in
China during the last two decades has inevitably increased the release of these
chemicals into environmental waters. In some areas, especially in regions with
intensive industrial activities, the level usually exceeds above average. The level of
PFOS has been detected even greater than 100 ng/l in Pear River near the city of
Dongguan Guangdong province of China(So et al., 2007). The industries in this city
were heavily involved in the production of plastics, electrical equipments and
telecommunication equipments developed during 1980 and 1997(Nolan, 2001). Many
of these industries could potentially involve the use of PFOS and other PFCs during
their manufacturing processes. The level of PFOS in drinking water in Shanghai, the
most important special economic zone of china, was also found to be higher than 10
ng/l(So et al., 2007).
Current water purification practices, including slow sand filtration and
chlorination, were ineffective in removing PFOS(Loos et al., 2007). Other methods
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have also been tried to increase the effectiveness of PFOS removing. Tang et al.
investigated the use of reverse osmosis (RO) membranes and nanofiltration (NF)
membranes to remove PFOS from wastewater. A greater than 99% and 90%–99%
removal was achieved with RO and NF membranes, respectively(Tang et al., 2006;
Tang et al., 2007). With the installation of granular activated carbon (GAC) system
into the wastewater treatment system of the PFOS production facility in Minnesota,
PFOS was successfully removed from the effluent discharged into the Mississippi
River. These new technologies, however, have not currently been well implemented.
Combined with the ineffective wastewater treatment, the increase in the
manufacturing and use of PFOS and related chemicals pose a continuous threat to the
environment and human health. Taken together, rigorous monitoring of PFOS in
environmental and drinking waters with rapid, cost-effective and robust tool can help
to evaluate the level of environment contamination and the effectiveness of water
treatment practice in PFOS and related chemical industries, benefiting both
environment and human health.
5. Conclusion
We have developed a QDs bioassay for convenient, cost effective and robust
detection of PFOS in water samples. This bioassay has detection limit of 2.5ng/l with
linearity range of 2.5ng/l-75ng/l, providing an alternative to HPLC/MS for detection
and monitoring of PFOS in environmental water and drinking water, and also for
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evaluating the effectiveness of water treatment for removing PFOS and related
chemicals.
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Figure legends:
Figure 1. Absorption and emission spectra of QDs-SA
a Absorption spectra of QDs-SA. b. Emission spectra of QDs-SA.
Figure2. Schematic illustration of the bioassay using QD-streptavidin-biotin-modified
oligonucleotide probes.
(1). Plate was coated with PFOS-BSA; (2). PFOS standard/sample and PPARα-RXRα
were added; (3). Supernatants were transferred to another plate coated with PPARα
antibody; (4). Biotin modified probes were added; (5) QDs-SA was added.
Figure 3. Quantification of PFOS in standard solutions with the bioassay using
QD-streptavidin-biotin-modified oligonucleotide probes. The curve shows the
linearity between fluorescence intensities against corresponding concentrations of
PFOS. Each value represents the mean ± SD of triplicate independent determinations.
0.05%DMSO was used as a control.
Figure 4. Quantification of PFOS in standard solutions with HPLC/MS. The curve
shows the linearity between absorption peaks against corresponding concentrations of
PFOS. Each value represents the mean ± SD of triplicate independent determinations.
0.05%DMSO was used as a control.
Figure 5. Representative HPLC/MS spectra of PFOS in environmental water
samples. Environmental water samples were prepared and analyzed for PFOS by
HPLC/MS as described in the materials and methods section.
a. PFOS of chromatogram; b. PFOS of mass spectrogram
Table.1 Analytical parameters of the two methods for PFOS quantification
1The Detection limits were calculated by S/N=3
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Table.2 Quantification of PFOS in environmental water samples with the bioassay
and HPLC/MS
